Universal Time: 22:29  |  Local Time: 22:29 (3h GMT)
Select your timezone:
Reset

Mon Sep 23

10:40 - 12:10 Abstract Session: Kidney Outcomes 1
Polyomavirus perspective from a pathologies
Binnaz Handan Ozdemir, Turkey
10:40 - 12:10 Abstract Session: Organ preservatiion, pre-conditioning and IRI
B-Cell and biomarkers
Anita Chong, United States
10:40 - 12:10 Abstract Session: Advances in cell transplantation
Ethics in cell transplantation
Marwan Masri, Lebanon
10:40 - 12:10 Abstract Session: HLA histocompatibility
Donor microvascular culture assay
Medhat Askar, Qatar
10:40 - 12:10 Abstract Session: Sex & gender in transplantation
Impact of sex and microbiome on ABO antibodies
Lori J. West, Canada
13:40 - 15:10 Abstract Session: General infectious diseases 1
RSV Vaccine
Camille N. Kotton, United States
13:40 - 15:10 Abstract Session: Immune monitoring and Biomarkers
Novel biomarkers
Jonathan Bromberg, United States
13:40 - 15:10 Abstract Session: Kidney Transplant Management Challenges 1
Commercial kidney transplantation - social demographic challenges
Huda Al-Taee, Iraq
13:40 - 15:10 Abstract Session: Surgical and anesthesia issues: Through a donation lens-then societal factors
Technique to reduce IRI
Henry Pleass, Australia
13:40 - 15:10 Abstract Session: Tackling global ethical issues in transplantation
What next for transplant ethics in the era of xenotransplantation?
Dominique Martin, Australia
13:40 - 15:10 Abstract Session: Predictive model in transplantation
Predicting kidney allograft rejection using blood biomarkers: a prospective multicenter unselected cohort study (EU-TRAIN)
Valentin Goutaudier, France
16:50 - 18:30 Abstract Session: Kidney: ABO incompatibility, HLA and Donor Characteristics
ABO-incompatible Living Kidney Transplantation
Kazunari Tanabe, Japan
16:50 - 18:30 Abstract Session: Immunoregulation, tolerance and other topics
Infectious tolerance
Megan Sykes, United States
16:50 - 18:30 Abstract Session: Lung Transplantation
Lung preservation technique
Shafique Keshavjee, Canada

Tue Sep 24

08:00 - 09:15 Abstract Session: Kidney Deceased Donor Issues
Organ donation in the Middle-East
Anwar Naqvi, Pakistan
08:00 - 09:15 Abstract Session: Liver complications & techniques
Surgical complications on liver
Nancy L. Ascher, United States
08:00 - 09:15 Abstract Session: Transplant immunosuppression 2
Immunosuppression in kidney Tx for children
Esra Baskin, Turkey
10:40 - 12:10 Abstract Session: Allocation and utilization
Maximizing deceased organ donation in the Middle-East
Katayoun Najafizadeh, Iran
10:40 - 12:10 Abstract Session: Biomarkers and immune monitoring
Tracking the effectors of allograft rejection
Alexandra Sharland, Australia
10:40 - 12:10 Abstract Session: Heart transplantation
Heart Xenotransplantation
Robert A Montgomery, United States
13:40 - 15:10 Abstract Session: Patient centered care in Tx
TBD
Lorna Marson, United Kingdom
13:40 - 15:10 Abstract Session: General Infectious Diseases 2
An emerging issue: Carbapenem resistant enterobacteriaceae in solid-organ tx
Hande Arslan, Turkey
13:40 - 15:10 Abstract Session: Cutting-edge of VCA transplantation
The world’s first combined face and whole-eye transplant: Technical aspects, surgical underpinnings, and 1-year outcomes
Bruce E. Gelb, United States
16:50 - 18:30 Abstract Session: Pediatric transplant 2
Kidney failure in Middle-Eastern pediatric population
Hala Wannous, Syrian Arab Republic

Wed Sep 25

08:00 - 09:15 Abstract Session: Ethics in organ donation
Improving deceased organ donation among muslim living globally
Riadh A.S. Fadhil, Qatar
08:00 - 09:15 Abstract Session: Kidney Pre-Transplant Management
Cardiac screening pre-transplant
Steven J. Chadban, Australia
08:00 - 09:15 Abstract Session: Kidney Transplant - Donor and Recipient Issues
The US model of continuous distribution of donated organs: Better or worse
Matthew Cooper, United States
08:00 - 09:15 Abstract Session: Novel therapeutics and immunosuppression strategies 2
Microbiome modification for immune regulation
Maria-Luisa Alegre, United States
13:40 - 15:10 Abstract Session: Kidney Outcomes and Complications 2
Rejection post-transplant
Faissal Shaheen, Saudi Arabia
© 2024 TTS 2024